16-31093399-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_024006.6(VKORC1):c.196G>A(p.Val66Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000151 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024006.6 missense
Scores
Clinical Significance
Conservation
Publications
- vitamin K-dependent clotting factors, combined deficiency of, type 2Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- vitamin K-dependent clotting factors, combined deficiency of, type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VKORC1 | NM_024006.6 | c.196G>A | p.Val66Met | missense_variant | Exon 2 of 3 | ENST00000394975.3 | NP_076869.1 | |
VKORC1 | NM_001311311.2 | c.196G>A | p.Val66Met | missense_variant | Exon 2 of 4 | NP_001298240.1 | ||
VKORC1 | NM_206824.3 | c.173+1158G>A | intron_variant | Intron 1 of 1 | NP_996560.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VKORC1 | ENST00000394975.3 | c.196G>A | p.Val66Met | missense_variant | Exon 2 of 3 | 1 | NM_024006.6 | ENSP00000378426.2 | ||
ENSG00000255439 | ENST00000529564.1 | c.196G>A | p.Val66Met | missense_variant | Exon 2 of 5 | 4 | ENSP00000431371.1 |
Frequencies
GnomAD3 genomes AF: 0.000802 AC: 122AN: 152156Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.000195 AC: 49AN: 251118 AF XY: 0.0000958 show subpopulations
GnomAD4 exome AF: 0.0000828 AC: 121AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.0000715 AC XY: 52AN XY: 727244 show subpopulations
GnomAD4 genome AF: 0.000801 AC: 122AN: 152274Hom.: 0 Cov.: 30 AF XY: 0.000819 AC XY: 61AN XY: 74456 show subpopulations
ClinVar
Submissions by phenotype
Warfarin response Pathogenic:1
This variant has been previously reported in the literature in patients with warfarin resistance (PMID: 15630486). Functional studies demonstrate almost complete loss of activity for the p.Val66Met variant relative to wild type (PMID: 23039877). There are 70 reports of the variant as a heterozygous change in the population database, gnomAD, thus the variant is rare. The p.Val66Met residue is highly conserved among vertebrates, and the methionine substitution is predicted to be damaging by in silico models. Based on the combined evidence, the variant is classified as pathogenic. -
Vitamin K-dependent clotting factors, combined deficiency of, type 2 Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at